SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-21-029184
Filing Date
2021-02-26
Accepted
2021-02-26 16:10:28
Documents
7
Period of Report
2021-02-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm218114d1_8k.htm 8-K/A 26780
2 EXHIBIT 1.1 tm218114d1_ex1-1.htm EX-1.1 242651
3 EXHIBIT 4.1 tm218114d1_ex4-1.htm EX-4.1 110217
4 EXHIBIT 5.1 tm218114d1_ex5-1.htm EX-5.1 14466
5 EXHIBIT 99.1 tm218114d1_ex99-1.htm EX-99.1 12683
6 EXHIBIT 99.2 tm218114d1_ex99-2.htm EX-99.2 12852
7 GRAPHIC tm218114d1_ex5-1img01.jpg GRAPHIC 10160
  Complete submission text file 0001104659-21-029184.txt   435053
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37619 | Film No.: 21688828
SIC: 2834 Pharmaceutical Preparations